世界のバイオプロテーゼ（生体補綴）市場は、2024年に59.1億米ドルと評価され、2035年には95.9億米ドルに達すると予測されており、予測期間（2024年〜2035年）の年間平均成長率（CAGR）は4.5％です。バイオプロテーゼは同種移植材（アログラフト）および異種移植材（ゼノグラフト）の両方を含み、医療分野において高い機能性と生物学的適合性を持つ組織や臓器の修復のための重要な基盤を提供しています。心臓弁の置換手術、再建手術、先進的な創傷治癒手術における生理学的適合性および患者アウトカムに対するニーズの高まりが、バイオプロテーゼの受容性を加速させています。
バイオプロテーゼ材料は、低侵襲性を重視し、患者中心の回復を促進する医療システムの枠組みの進化とともに、受容性が高まっています。心臓弁疾患を含む心血管疾患は、世界的に重要な死亡原因の一つであるため、医療機器分野では生体適合性と耐久性を兼ね備えた次世代の人工臓器開発に注力しています。プラスチック材料や再建外科手術の進歩により、市場機会はさらに拡大しており、外科医は生体由来の材料を使用して宿主組織と自然に統合され、効果的に治癒を促進することにより積極的になっています。
安全性、有効性、トレーサビリティは、規制当局によって強く重視される項目であり、これらはイノベーションの速度にも影響を与えています。そのため、製造業者は材料科学分野、免疫原性の低減、製造精度の向上に関して、研究開発への多額の投資を余儀なくされています。さらに、慢性創傷、火傷、複雑な外傷症例の増加により、創傷治癒におけるバイオプロテーゼ材料の適用範囲は拡大しており、組織再生を促進するとともに瘢痕形成を最小限に抑えるという追加の利点も得られます。このように、業界の軌跡は、臨床需要、規制の進化、技術革新が相互に作用する形で特徴付けられます。
Edwards Lifesciences、Medtronic、Boston Scientific、LivaNova、Labcor Laboratórios、CryoLife、Lepu Medical、Meril Life Sciences、Braile Biomédica、TTK Healthcare
目次
Chapter 1. Market Snapshot
1.1. Market Definition & Report Overview
1.2. Market Segmentation
1.3. Key Takeaways
1.3.1. Top Investment Pockets
1.3.2. Top Winning Strategies
1.3.3. Market Indicators Analysis
1.3.4. Top Impacting Factors
1.4. Application Ecosystem Analysis
1.4.1. 360’ Analysis
Chapter 2. Executive Summary
2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Market Attractiveness Analysis (top leader’s point of view on the market)
2.5. Key Findings
Chapter 3. Research Methodology
3.1. Research Objective
3.2. Supply Side Analysis
3.2.1. Primary Research
3.2.2. Secondary Research
3.3. Demand Side Analysis
3.3.1. Primary Research
3.3.2. Secondary Research
3.4. Forecasting Models
3.4.1. Assumptions
3.4.2. Forecasts Parameters
3.5. Competitive breakdown
3.5.1. Market Positioning
3.5.2. Competitive Strength
3.6. Scope of the Study
3.6.1. Research Assumption
3.6.2. Inclusion & Exclusion
3.6.3. Limitations
Chapter 4. Industry Landscape
4.1. Market Dynamics
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Porter’s 5 Forces Model
4.2.1. Bargaining Power of Buyer
4.2.2. Bargaining Power of Supplier
4.2.3. Threat of New Entrants
4.2.4. Threat of Substitutes
4.2.5. Competitive Rivalry
4.3. Value Chain Analysis
4.4. PESTEL Analysis
4.5. Pricing Analysis and Trends
4.6. Key growth factors and trends analysis
4.7. Market Share Analysis (2024)
4.8. Top Winning Strategies (2024)
4.9. Trade Data Analysis (Import Export)
4.10. Regulatory Guidelines
4.11. Historical Data Analysis
4.12. Analyst Recommendation & Conclusion
Chapter 5. Global Bioprosthetics Market Size & Forecasts by Product 2024-2035
5.1. Market Overview
5.1.1. Market Size and Forecast By Product 2024-2035
5.2. Allograft
5.2.1. Market definition, current market trends, growth factors, and opportunities
5.2.2. Market size analysis, by region, 2024-2035
5.2.3. Market share analysis, by country, 2024-2035
5.3. Xenograft
5.3.1. Market definition, current market trends, growth factors, and opportunities
5.3.2. Market size analysis, by region, 2024-2035
5.3.3. Market share analysis, by country, 2024-2035
Chapter 6. Global Bioprosthetics Market Size & Forecasts by Industry 2024-2035
6.1. Market Overview
6.1.1. Market Size and Forecast By Industry 2024-2035
6.2. Cardiovascular
6.2.1. Market definition, current market trends, growth factors, and opportunities
6.2.2. Market size analysis, by region, 2024-2035
6.2.3. Market share analysis, by country, 2024-2035
6.3. Plastic Surgery & Wound Healing
6.3.1. Market definition, current market trends, growth factors, and opportunities
6.3.2. Market size analysis, by region, 2024-2035
6.3.3. Market share analysis, by country, 2024-2035
Chapter 7. Global Bioprosthetics Market Size & Forecasts by Region 2024-2035
7.1. Regional Overview 2024-2035
7.2. Top Leading and Emerging Nations
7.3. North America Bioprosthetics Market
7.3.1. U.S. Bioprosthetics Market
7.3.1.1. Product breakdown size & forecasts, 2024-2035
7.3.1.2. Industry breakdown size & forecasts, 2024-2035
7.3.2. Canada Bioprosthetics Market
7.3.2.1. Product breakdown size & forecasts, 2024-2035
7.3.2.2. Industry breakdown size & forecasts, 2024-2035
7.3.3. Mexico Bioprosthetics Market
7.3.3.1. Product breakdown size & forecasts, 2024-2035
7.3.3.2. Industry breakdown size & forecasts, 2024-2035
7.4. Europe Bioprosthetics Market
7.4.1. UK Bioprosthetics Market
7.4.1.1. Product breakdown size & forecasts, 2024-2035
7.4.1.2. Industry breakdown size & forecasts, 2024-2035
7.4.2. Germany Bioprosthetics Market
7.4.2.1. Product breakdown size & forecasts, 2024-2035
7.4.2.2. Industry breakdown size & forecasts, 2024-2035
7.4.3. France Bioprosthetics Market
7.4.3.1. Product breakdown size & forecasts, 2024-2035
7.4.3.2. Industry breakdown size & forecasts, 2024-2035
7.4.4. Spain Bioprosthetics Market
7.4.4.1. Product breakdown size & forecasts, 2024-2035
7.4.4.2. Industry breakdown size & forecasts, 2024-2035
7.4.5. Italy Bioprosthetics Market
7.4.5.1. Product breakdown size & forecasts, 2024-2035
7.4.5.2. Industry breakdown size & forecasts, 2024-2035
7.4.6. Rest of Europe Bioprosthetics Market
7.4.6.1. Product breakdown size & forecasts, 2024-2035
7.4.6.2. Industry breakdown size & forecasts, 2024-2035
7.5. Asia Pacific Bioprosthetics Market
7.5.1. China Bioprosthetics Market
7.5.1.1. Product breakdown size & forecasts, 2024-2035
7.5.1.2. Industry breakdown size & forecasts, 2024-2035
7.5.2. India Bioprosthetics Market
7.5.2.1. Product breakdown size & forecasts, 2024-2035
7.5.2.2. Industry breakdown size & forecasts, 2024-2035
7.5.3. Japan Bioprosthetics Market
7.5.3.1. Product breakdown size & forecasts, 2024-2035
7.5.3.2. Industry breakdown size & forecasts, 2024-2035
7.5.4. Australia Bioprosthetics Market
7.5.4.1. Product breakdown size & forecasts, 2024-2035
7.5.4.2. Industry breakdown size & forecasts, 2024-2035
7.5.5. South Korea Bioprosthetics Market
7.5.5.1. Product breakdown size & forecasts, 2024-2035
7.5.5.2. Industry breakdown size & forecasts, 2024-2035
7.5.6. Rest of APAC Bioprosthetics Market
7.5.6.1. Product breakdown size & forecasts, 2024-2035
7.5.6.2. Industry breakdown size & forecasts, 2024-2035
7.6. LAMEA Bioprosthetics Market
7.6.1. Brazil Bioprosthetics Market
7.6.1.1. Product breakdown size & forecasts, 2024-2035
7.6.1.2. Industry breakdown size & forecasts, 2024-2035
7.6.2. Argentina Bioprosthetics Market
7.6.2.1. Product breakdown size & forecasts, 2024-2035
7.6.2.2. Industry breakdown size & forecasts, 2024-2035
7.6.3. UAE Bioprosthetics Market
7.6.3.1. Product breakdown size & forecasts, 2024-2035
7.6.3.2. Industry breakdown size & forecasts, 2024-2035
7.6.4. Saudi Arabia (KSA Bioprosthetics Market
7.6.4.1. Product breakdown size & forecasts, 2024-2035
7.6.4.2. Industry breakdown size & forecasts, 2024-2035
7.6.5. Africa Bioprosthetics Market
7.6.5.1. Product breakdown size & forecasts, 2024-2035
7.6.5.2. Industry breakdown size & forecasts, 2024-2035
7.6.6. Rest of LAMEA Bioprosthetics Market
7.6.6.1. Product breakdown size & forecasts, 2024-2035
7.6.6.2. Industry breakdown size & forecasts, 2024-2035
Chapter 8. Company Profiles
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. VAT Group AG
8.2.1.1. Company Overview
8.2.1.2. Key Executives
8.2.1.3. Company Snapshot
8.2.1.4. Financial Performance (Subject to Data Availability)
8.2.1.5. Product/Services Port
8.2.1.6. Recent Development
8.2.1.7. Market Strategies
8.2.1.8. SWOT Analysis
8.2.2. Pfeiffer Vacuum Technology AG
8.2.3. MKS Instruments, Inc.
8.2.4. CKD Corporation
8.2.5. ULVAC, Inc.
8.2.6. Agilent Technologies
8.2.7. SMC Corporation
8.2.8. HVA LLC
8.2.9. Fujikin Incorporated
8.2.10. Edwards Vacuum
